Long-term outcomes of salvage transurethral high-dose-rate brachytherapy combined with external beam radiation therapy for anastomotic recurrence of prostate cancer after radical prostatectomy: A retrospective analysis.
Kenta WatanabeNobuhiko KamitaniNaoki IkedaYujiro KawataRyoji TokiyaTakafumi HayashiYoshiyuki MiyajiTsutomu TamadaKuniaki KatsuiPublished in: Brachytherapy (2024)
No prostate cancer-related deaths were observed, even after a long-term follow-up. Salvage transurethral HDR-BT after radical prostatectomy is safe and feasible and may be a useful treatment option.